Estimating the returns to UK publicly funded cancer-related research in terms of the net value of improved health outcomes / Matthew Glover, Martin Buxton, Susan Guthrie, Stephen Hanney, Alexandra Pollit and Jonathan Grant.
- Glover, Matthew
About this work
Following a ground breaking study published in 2008, which yielded the first quantitative assessment of the economic benefit of biomedical and health science in the UK, the Wellcome Trust, Cancer Research UK, the Department for Health and the Academy of Medical Sciences commissioned this new study to develop the methodology and calculate the economic benefits of investment in cancer-related research by the taxpayer and charities in the UK. The results of this study strongly suggest that biomedical research provides a sizeable return on investment.